Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q4 2019 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2020-02-14

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value: $232M (100.0% shares, 0.0% debt)

Holdings (14)

— Aerie Pharmaceuticals, Inc. 15.7%

Value $36.29M Shares 1,501,400 Est. Cost $24.60 Unrealized —

— The Medicines Company 14.8%

Value $34.25M Shares 403,217 Est. Cost $42.94 Unrealized —

INSM Insmed Incorporated 14.7%

Value $34.14M Shares 1,429,518 Est. Cost $26.85 Unrealized -24.2%

CYTK Cytokinetics Incorporated 11.0%

Value $25.45M Shares 2,398,970 Est. Cost $8.13 Unrealized +26.4%

FULC Fulcrum Therapeutics, Inc. 10.8%

Value $24.96M Shares 1,500,000 Est. Cost $11.06 Unrealized -13.6%

— Myokardia, Inc. 8.2%

Value $18.98M Shares 260,370 Est. Cost $47.74 Unrealized —

VYGR Voyager Therapeutics, Inc. 5.0%

Value $11.59M Shares 830,565 Est. Cost $21.95 Unrealized —

ABUS Arbutus BioPharma Corp. 4.4%

Value $10.3M Shares 3,705,128 Est. Cost $1.62 Unrealized 0.0%

ASND Ascendis Pharma A/S 4.1%

Value $9.597M Shares 68,981 Est. Cost $40.06 Unrealized —

— OptiNose, Inc. 3.5%

Value $8.028M Shares 870,766 Est. Cost $15.00 Unrealized —

SIBN SI-BONE, Inc. 2.9%

Value $6.626M Shares 308,183 Est. Cost $18.59 Unrealized -3.5%

ALEC Alector, Inc. 2.6%

Value $6.09M Shares 353,462 Est. Cost $18.92 Unrealized -10.1%

— CymaBay Therapeutics, Inc. 2.0%

Value $4.537M Shares 2,315,016 Est. Cost $8.13 Unrealized —

KURA Kura Oncology, Inc. 0.4%

Value $935K Shares 68,000 Est. Cost $14.82 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Aerie Pharmaceuticals, Inc.	1,501,400	$36.29M	15.7%	$24.60	—	COM	00771V108
—	The Medicines Company	403,217	$34.25M	14.8%	$42.94	—	COM	584688105
INSM	Insmed Incorporated	1,429,518	$34.14M	14.7%	$26.85	-24.2%	COM	457669307
CYTK	Cytokinetics Incorporated	2,398,970	$25.45M	11.0%	$8.13	+26.4%	COM NEW	23282W605
FULC	Fulcrum Therapeutics, Inc.	1,500,000	$24.96M	10.8%	$11.06	-13.6%	COM	359616109
—	Myokardia, Inc.	260,370	$18.98M	8.2%	$47.74	—	COM	62857M105
VYGR	Voyager Therapeutics, Inc.	830,565	$11.59M	5.0%	$21.95	—	COM	92915B106
ABUS	Arbutus BioPharma Corp.	3,705,128	$10.3M	4.4%	$1.62	0.0%	COM	03879J100
ASND	Ascendis Pharma A/S	68,981	$9.597M	4.1%	$40.06	—	SPONSORED ADR	04351P101
—	OptiNose, Inc.	870,766	$8.028M	3.5%	$15.00	—	COM	68404V100
SIBN	SI-BONE, Inc.	308,183	$6.626M	2.9%	$18.59	-3.5%	COM	825704109
ALEC	Alector, Inc.	353,462	$6.09M	2.6%	$18.92	-10.1%	COM	014442107
—	CymaBay Therapeutics, Inc.	2,315,016	$4.537M	2.0%	$8.13	—	COM	23257D103
KURA	Kura Oncology, Inc.	68,000	$935K	0.4%	$14.82	0.0%	COM	50127T109